Max Robotics — Global Service Robot Directory + US Certification

About

Bannakij Lojanapiwat is a leading urologic oncologist whose research has significantly advanced the understanding and management of prostate cancer, particularly within Asian populations. His major contributions center on elucidating the distinct epidemiological and clinical characteristics of prostate cancer in Asia, challenging the direct application of Western treatment paradigms. As a key figure in the landmark Asian Prostate Cancer (A-CaP) study, he co-authored the influential "Report of the third Asian Prostate Cancer study meeting" (2018, 12 citations), which established a critical multinational registry to analyze patient demographics, treatment patterns, and outcomes across the region. This work has been instrumental in identifying disparities in disease presentation and survival, paving the way for region-specific clinical guidelines. Dr. Lojanapiwat’s dedication to collaborative, large-scale data collection has provided an invaluable foundation for future research, directly impacting clinical decision-making for thousands of patients. His leadership in this initiative underscores his commitment to bridging global knowledge gaps and improving prostate cancer care across Asia.